POSEIDON PHARMACEUTICALS AS

Overview

Total Patents

20

About

POSEIDON PHARMACEUTICALS AS has a total of 20 patent applications. Its first patent ever was published in 1991. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are PARATEK PHARM INNC, ANSORGE SIEGFRIED and ZHEJIANG DADE PHARMACEUTICAL GROUP CO LTD.

Map
Trends
Similars
Markets
Inventors
List

Patent filings in countries

World map showing POSEIDON PHARMACEUTICALS ASs patent filings in countries

#	Country	Total Patents
#1	WIPO (World Intellectual Property Organization)	8
#2	United States	4
#3	Australia	3
#4	EPO (European Patent Office)	2
#5	Canada	1
#6	China	1
#7	Mexico	1

Patent filings per year

Chart showing POSEIDON PHARMACEUTICALS ASs patent filings per year from 1900 to 2020

Similar Companies

PARATEK PHARM INNC 100% similarity

ANSORGE SIEGFRIED 100% similarity

ZHEJIANG DADE PHARMACEUTICAL GROUP CO LTD 99% similarity

NICOX SA 99% similarity

BHAT LAXMINARAYAN 99% similarity

LEO FARMA AS 99% similarity

NUFORMIX LTD 99% similarity

ORTHO MCNEIL PHARMACEUTICAL CO 99% similarity

MAKRIYANNIS ALEXANDROS 99% similarity

BIOELECTRON TECH CORP 99% similarity

Focus industries

#	Industry
#1	Pharmaceuticals
#2	Organic fine chemistry
#3	Environmental technology

Focus technologies

#	Technology
#1	Therapeutic chemical compounds
#2	Medical preparations
#3	Heterocyclic compounds
#4	Acyclic or carbocyclic compounds
#5	Special acyclic compounds
#6	Climate change adaptation technologies

Top inventors

#	Name	Total Patents
#1	Madsen Lars Siim	9
#2	Demnitz Joachim	9
#3	Olesen Soeren Peter	7
#4	Christophersen Palle	5
#5	Stroebaek Dorte	5
#6	Teuber Lene	4
#7	Gouliaev Alex Haahr	4
#8	Lauridsen Annette	4
#9	Hansen Rie S	4
#10	Baek Camilla Aerteberg	4

Latest patents

Publication	Filing date	Title
WO2005023238A1	2004-09-06	Erg channel openers for the treatment of hyperexcitability-related neuronal diseases
WO2005003094A1	2004-06-30	Diarylmethyl derivatives as potassium channel modulators
WO2005003143A1	2004-06-30	Novel potassium channel modulators
EP1519923A1	2003-06-17	Novel benzimidazol-2-one derivatives and their use
WO03004010A1	2002-06-26	Carbonylamino derivatives useful for obtaining immune regulation
WO03000245A1	2002-06-20	Compounds for use in disorders associated with mast cell or basophil activity